Stay updated on Preventing GvHD in Allo ApoGraft SCT - Clinical Trial
Sign up to get notified when there's something new on the Preventing GvHD in Allo ApoGraft SCT - Clinical Trial page.

Latest updates to the Preventing GvHD in Allo ApoGraft SCT - Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0 on the site; no user-visible content or data changes are indicated in the screenshot.SummaryDifference0.1%

- Check15 days agoChange DetectedRevision history adds Revision: v3.4.3 and removes Revision: v3.4.2.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check43 days agoChange DetectedRevision: v3.4.2 was added to the history, and the older funding notice and revision v3.4.1 were removed.SummaryDifference0.8%

- Check50 days agoChange DetectedA site-wide notice regarding government funding was added and the revision history shows a new revision v3.4.1, with the previous v3.4.0 entry removed.SummaryDifference0.8%

- Check57 days agoChange DetectedThe record history page now shows additions in green and deletions in red, adds a Show glossary option, and updates the revision label to v3.4.0 while removing the prior No FEAR Act data note. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1%

- Check72 days agoChange DetectedThe history adds revision v3.3.4, replacing v3.3.3. No study details or outcomes appear to be affected.SummaryDifference0.1%

Stay in the know with updates to Preventing GvHD in Allo ApoGraft SCT - Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Preventing GvHD in Allo ApoGraft SCT - Clinical Trial page.